Wearable Cardiac Devices Market Analysis

Wearable Cardiac Devices Market Analysis

Defibrillators segment in the wearable cardiac devices market is projected to witness 22.9% growth rate through 2027. Wearable defibrillators provide outpatient heart health management, thereby reducing the risk of ventricular tachycardia (VT) and ventricular fibrillation (VF). Further, introduction of wearable technology in defibrillators has increased its application, thereby increasing its acceptance rate.
 

Home healthcare segment is estimated to attain a CAGR of 25.4% till 2027, led by the rising geriatric population base suffering with cardiovascular disorders. Moreover, wearable trackers providing efficient monitoring of heart rate and allows access to real time data that helps in identifying risks and reduces hospital visits. Therefore, continuous monitoring of cardiac conditions at home through wearable devices will lead to reduced visits to hospitals, thereby increasing its usage during the forecast period.
 

North America wearable cardiac devices market captured over 60% of revenue share in 2020 impelled by the increasing number of research studies and technological advancement of wearable cardiac devices. Additionally, rising prevalence of cardiovascular diseases significantly contribute to the adoption of wearable monitors among patients, thereby stimulating its demand in the region.
 

The region is showcasing large number of new entrants manufacturing wearables, especially in the U.S. Some of the emerging firms include Qardio, VitalConnect, Proteus Digital Health, Cardiomo and Hemodynamics Company LLC among several others. Furthermore, growing usage of remote monitoring devices will propel the regional revenue in the coming years.